Paolo Manfredi, MD, PhD

MGGM Therapeutics
Kerhonkson, New York, United States

Disclosure information not submitted.

Presentation(s):

• ORF15-01 - Non-Psychedelic Psilocin Derivative Induces Beneficial Hepatic Lipidome Remodeling and Metabolic Improvement in Diet-Induced MASLD

  Saturday, June 13, 2026
  1:45 PM - 1:50 PM CT

• SUN-711 - Non-Psychedelic Psilocin Derivative Induces Beneficial Hepatic Lipidome Remodeling and Metabolic Improvement in Diet-Induced MASLD

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT